Castle Biosciences (CSTL) Change in Acquisitions & Divestments (2023 - 2026)
Castle Biosciences' Change in Acquisitions & Divestments history spans 3 years, with the latest figure at $54.0 million for Q4 2025.
- On a quarterly basis, Change in Acquisitions & Divestments rose 143.81% to $54.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $189.2 million, a N/A change, with the full-year FY2025 number at $189.2 million, changed N/A from a year prior.
- Change in Acquisitions & Divestments hit $54.0 million in Q4 2025 for Castle Biosciences, down from $54.9 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for CSTL hit a ceiling of $54.9 million in Q3 2025 and a floor of -$123.2 million in Q4 2024.
- Historically, Change in Acquisitions & Divestments has averaged $31.3 million across 3 years, with a median of $44.5 million in 2023.
- Biggest five-year swings in Change in Acquisitions & Divestments: crashed 354.12% in 2024 and later skyrocketed 143.81% in 2025.
- Tracing CSTL's Change in Acquisitions & Divestments over 3 years: stood at $48.5 million in 2023, then crashed by 354.12% to -$123.2 million in 2024, then soared by 143.81% to $54.0 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for CSTL at $54.0 million in Q4 2025, $54.9 million in Q3 2025, and $44.0 million in Q2 2025.